Comparative risk of hepatocellular carcinoma and mortality among initiators of GLP-1 receptor agonists versus other glucose-lowering therapies: a target trial emulation. uri icon

authors

  • Hernández-Pérez, Jesus Gibran
  • Messiah, Sarah E
  • Lopez, David S
  • Abdelgadir, Omer
  • Jang, Subin
  • Ernest, Deepali K
  • Rony Zhang, MD, PhD
  • Shah, Dimpy
  • Hong, Arthur S
  • Almandoz, Jaime P
  • Cowell, Lindsay G

publication date

  • August 12, 2026